Activating mutations in the PI3K catalytic subunit alpha (PIK3CA) are the most common genetic alteration in HR+ breast cancer, present in approximately 35% of metastatic cases (Martínez-Sáez et al., 2020), and are strongly associated with poor prognosis (Zardavas et al., 2018). This evidence concerns the gene PIK3CA and breast carcinoma.